NUCYNTA IR 75 MG
TAPENTADOL (TAPENTADOL HYDROCHLORIDE) : 75 MG · DIN 02378280 · ENDO OPERATIONS LTD.
Health Canada status: MARKETED
What is NUCYNTA IR?
NUCYNTA IR 75 MG contains TAPENTADOL (TAPENTADOL HYDROCHLORIDE) : 75 MG. It is listed in the Health Canada Drug Product Database under DIN 02378280, held by ENDO OPERATIONS LTD., supplied as TABLET (IMMEDIATE RELEASE) for ORAL administration. Health Canada currently lists it as marketed, status dated 06-Mar-2026. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02378280 |
|---|---|
| Brand name | NUCYNTA IR |
| Generic / active ingredient | TAPENTADOL (TAPENTADOL HYDROCHLORIDE) : 75 MG |
| Manufacturer | ENDO OPERATIONS LTD. |
| Strength | 75 MG |
| Dosage form | TABLET (IMMEDIATE RELEASE) |
| Route of administration | ORAL |
| Schedule | NARCOTICS (CDSA I) |
| ATC code | N02AX06 TAPENTADOL |
| AHFS class | 08:14.08 |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 06-Mar-2026 |
| Original market date | 2012-03-05 00:00:00 |
What can be used instead?
Other Canadian products sharing ATC code N02AX06 TAPENTADOL. 8 of 16 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| NUCYNTA EXTENDED-RELEASE | 100 MG | TABLET (EXTENDED-RELEASE) | ENDO OPERATIONS LTD. | MARKETED | DIN 02415585 |
| NUCYNTA EXTENDED-RELEASE | 150 MG | TABLET (EXTENDED-RELEASE) | ENDO OPERATIONS LTD. | MARKETED | DIN 02415593 |
| NUCYNTA EXTENDED-RELEASE | 200 MG | TABLET (EXTENDED-RELEASE) | ENDO OPERATIONS LTD. | MARKETED | DIN 02415607 |
| NUCYNTA EXTENDED-RELEASE | 250 MG | TABLET (EXTENDED-RELEASE) | ENDO OPERATIONS LTD. | MARKETED | DIN 02415615 |
| NUCYNTA EXTENDED-RELEASE | 50 MG | TABLET (EXTENDED-RELEASE) | ENDO OPERATIONS LTD. | MARKETED | DIN 02415577 |
| NUCYNTA IR | 100 MG | TABLET (IMMEDIATE RELEASE) | ENDO OPERATIONS LTD. | MARKETED | DIN 02378299 |
| NUCYNTA IR | 50 MG | TABLET (IMMEDIATE RELEASE) | ENDO OPERATIONS LTD. | MARKETED | DIN 02378272 |
| APO-TAPENTADOL | 100 MG | TABLET (IMMEDIATE RELEASE) | APOTEX INC | APPROVED | DIN 02471981 |
| APO-TAPENTADOL | 50 MG | TABLET (IMMEDIATE RELEASE) | APOTEX INC | APPROVED | DIN 02471965 |
| APO-TAPENTADOL | 75 MG | TABLET (IMMEDIATE RELEASE) | APOTEX INC | APPROVED | DIN 02471973 |
Who else supplies TAPENTADOL worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. TAPENTADOL appears in 87 registered pack listings across 8 markets, published on 8 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.